Amedisys Inc (STU:ADY)
€ 87 0 (0%) Market Cap: 2.90 Bil Enterprise Value: 3.24 Bil PE Ratio: 0 PB Ratio: 2.87 GF Score: 85/100

Amedisys Inc at UBS Global Healthcare Conference Transcript

May 23, 2022 / 01:15PM GMT
Release Date Price: €119 (+3.48%)
Unidentified Analyst

Good morning. Welcome to day 1 of the UBS Healthcare Conference. It's my pleasure to welcome Amedisys on stage here. We have Chris Gerard, CEO; and Scott Ginn, Chief Financial Officer. Welcome.

Christopher T. Gerard
Amedisys, Inc. - CEO, President & Director

Good morning.

Questions & Answers

Unidentified Analyst

Chris, to start, maybe one of the main takeaways we had from the 1Q earnings season was that home health providers seems to be more resilient from a labor and earnings perspective compared to a lot of the acute hospital peers. Why are we starting to see a divergence in the labor pressure now?

Christopher T. Gerard
Amedisys, Inc. - CEO, President & Director

Yes. So I mean, I think that during the Q1 with the Omicron variant coming on, and I think the hospitals really being desperate for some clinicians and paying kind of wages that were not sustainable, we saw basically, the competition go up for the clinicians. For us, what we were able

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot